ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 149 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $839,006 | +2978.7% | 566,896 | +3249.1% | 0.01% | – |
| Q2 2023 | $27,252 | -98.6% | 16,927 | -97.4% | 0.00% | -100.0% |
| Q1 2023 | $1,899,080 | -39.9% | 654,855 | -32.0% | 0.01% | -42.9% |
| Q4 2022 | $3,159,533 | +135.3% | 963,272 | +171.1% | 0.02% | +90.9% |
| Q3 2022 | $1,343,000 | -26.0% | 355,325 | +204.4% | 0.01% | -8.3% |
| Q2 2021 | $1,815,000 | +83.7% | 116,722 | +69.7% | 0.01% | +50.0% |
| Q1 2021 | $988,000 | -35.1% | 68,774 | -41.5% | 0.01% | -50.0% |
| Q3 2020 | $1,523,000 | -18.5% | 117,539 | -8.4% | 0.02% | -20.0% |
| Q2 2020 | $1,869,000 | +1680.0% | 128,308 | +939.2% | 0.02% | +1900.0% |
| Q1 2020 | $105,000 | -80.7% | 12,347 | -62.7% | 0.00% | -80.0% |
| Q4 2019 | $545,000 | – | 33,080 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $3,280,000 | 10.95% |
| M28 Capital Management LP | 439,300 | $1,440,904 | 1.37% |
| Redmile Group, LLC | 6,242,756 | $20,476,240 | 0.84% |
| MAVERICK CAPITAL LTD | 6,291,013 | $20,634,523 | 0.49% |
| Baupost Group | 8,123,616 | $26,645 | 0.44% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 52,000 | $171 | 0.25% |
| WASATCH ADVISORS LP | 8,391,014 | $27,522,525 | 0.18% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $1,722,000 | 0.17% |
| STALEY CAPITAL ADVISERS INC | 450,000 | $1,476 | 0.09% |
| Virtus ETF Advisers LLC | 36,100 | $118,408 | 0.06% |